Company:  ENDOLOGIX INC /DE/ (ELGX)
Form Type:  8-K
Filing Date:  4/1/2019 
CIK:  0001013606 
Address:  2 MUSICK 
City, State, Zip:  IRVINE, California 92618 
Telephone:  (949) 598-4741 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$4.25  
Change: 
-0.11 (-2.52%)  
Trade Time: 
03:31 PM EST  
Market Cap: 
$74.85M
Trade ELGX now with

© 2019  
Description of Business
We develop, manufacture, market and sell innovative medical devices for the treatment of aortic disorders. Our products are intended for the minimally invasive endovascular treatment of abdominal aortic aneurysms ("AAA"). Our AAA products are built on one of two platforms: * Traditional minimally-invasive endovascular aneurysm repair ("EVAR"); or * Endovascular aneurysm sealing ("EVAS"), our innovative solution for sealing the aneurysm sac while maintaining blood flow. Our current EVAR products include the AFX® Endovascular AAA System (the "AFX System"), the VELA® Proximal Endograft ("VELA") and the Ovation® Abdominal Stent Graft System (the "Ovation System"). Our current EVAS product is the Nellix® Endovascular Aneurysm Sealing System (the "Nellix EVAS System").
Register and access this filing in:     
  FORM 8-K
    SECTION 1 BUSINESS AND OPERATIONS
      Item 1.01 Entry into a Material Definitive Agreement.
      Item 1.02 Termination of a Material Definitive Agreement.
    SECTION 2 FINANCIAL INFORMATION
      Item 2.02 Results of Operations and Financial Condition.
      Item 2.03 Creation of a Direct Financial Obligation or an ...
    SECTION 3 SECURITIES AND TRADING MARKETS
      Item 3.02 Unregistered Sales of Equity Securities.
    SECTION 8 OTHER EVENTS
      Item 8.01 Other Events.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01 Financial Statements and Exhibits.
    SIGNATURES
  EXHIBIT 4.1
  EXHIBIT 4.2
  EXHIBIT 4.3
  EXHIBIT 4.4
  EXHIBIT 4.5
  EXHIBIT 4.6
  EXHIBIT 4.7
  EXHIBIT 4.8
  EXHIBIT 5.1
  EXHIBIT 10.1
  EXHIBIT 10.2
  EXHIBIT 10.3
  EXHIBIT 10.4
  EXHIBIT 99.1